NIH Receives Nearly 50,000 Comments
Nearly 50,000 people have submitted their opinions to the National Institutes of Health regarding the new stem cell guidelines.
June 5, 2009
Nearly 50,000 people have submitted their opinions to the National Institutes of Health regarding the new stem cell guidelines.
Mesenchymal stem cells from Wharton’s jelly are found to improve pulmonary fibrosis.
As scientists await the final version of the NIH stem cell guidelines, expected in early July, the draft already proposed continues to attract debate.
The Madison, Wisconsin stem cell startup company, Cellular Dynamics, has announced the licensing of cardiovascular cells from New York’s Mount Sinai Medical School.
The adult stem cell company Fate Therapeutics announces treatment of the first patient in a Phase 1b clinical trial for hematopoietic stem cell support.
Embryonic stem cell scientists complain that the new NIH guidelines would severely restrict the federal funding of embryonic stem cell research.